These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18460300)

  • 1. Clinical inquiries. Which drugs are most effective for moderate to severe depression in adolescents?
    Guirguis-Blake J; Wright A; Rich J; Crawford J
    J Fam Pract; 2008 May; 57(5):330-2. PubMed ID: 18460300
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative efficacy of cognitive behavioral therapy, fluoxetine, and their combination in depressed adolescents: initial lessons from the treatment for adolescents with depression study.
    Pathak S; Kratochvil CJ; Rogers GM; Silva S; Vitiello B; Weller EB; March JS
    Curr Psychiatry Rep; 2005 Dec; 7(6):429-34. PubMed ID: 16318820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of depression treatment for adolescents.
    Norquist G; McGuire TG; Essock SM
    Am J Psychiatry; 2008 May; 165(5):549-52. PubMed ID: 18450932
    [No Abstract]   [Full Text] [Related]  

  • 4. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.
    March JS; Silva S; Petrycki S; Curry J; Wells K; Fairbank J; Burns B; Domino M; McNulty S; Vitiello B; Severe J
    Arch Gen Psychiatry; 2007 Oct; 64(10):1132-43. PubMed ID: 17909125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
    Goodyer IM; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
    Health Technol Assess; 2008 May; 12(14):iii-iv, ix-60. PubMed ID: 18462573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empirically supported treatments improve care of adolescents with depression.
    Lamberg L
    JAMA; 2008 Jul; 300(3):269-70. PubMed ID: 18632537
    [No Abstract]   [Full Text] [Related]  

  • 7. A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders.
    Riggs PD; Mikulich-Gilbertson SK; Davies RD; Lohman M; Klein C; Stover SK
    Arch Pediatr Adolesc Med; 2007 Nov; 161(11):1026-34. PubMed ID: 17984403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS).
    Vitiello B; Rohde P; Silva S; Wells K; Casat C; Waslick B; Simons A; Reinecke M; Weller E; Kratochvil C; Walkup J; Pathak S; Robins M; March J;
    J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1419-26. PubMed ID: 17135987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS).
    Curry J; Rohde P; Simons A; Silva S; Vitiello B; Kratochvil C; Reinecke M; Feeny N; Wells K; Pathak S; Weller E; Rosenberg D; Kennard B; Robins M; Ginsburg G; March J;
    J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1427-39. PubMed ID: 17135988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Turning darkness into light. A new landmark study on the treatment of adolescent depression. Comments on the TADS study.
    Apter A; Kronenberg S; Brent D
    Eur Child Adolesc Psychiatry; 2005 May; 14(3):113-6. PubMed ID: 15959656
    [No Abstract]   [Full Text] [Related]  

  • 11. The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial.
    Davey CG; Chanen AM; Hetrick SE; Cotton SM; Ratheesh A; Amminger GP; Koutsogiannis J; Phelan M; Mullen E; Harrison BJ; Rice S; Parker AG; Dean OM; Weller A; Kerr M; Quinn AL; Catania L; Kazantzis N; McGorry PD; Berk M
    Lancet Psychiatry; 2019 Sep; 6(9):735-744. PubMed ID: 31371212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of adolescent depression: what we have come to know.
    Vitiello B
    Depress Anxiety; 2009; 26(5):393-5. PubMed ID: 19404989
    [No Abstract]   [Full Text] [Related]  

  • 13. Adolescents with depression.
    Rifkin A; Rifkin W
    JAMA; 2004 Dec; 292(21):2577-8; author reply 2578-9. PubMed ID: 15572708
    [No Abstract]   [Full Text] [Related]  

  • 14. Adolescents with depression.
    Antonuccio D; Burns D
    JAMA; 2004 Dec; 292(21):2577; author reply 2578-9. PubMed ID: 15572709
    [No Abstract]   [Full Text] [Related]  

  • 15. Adolescents with depression.
    Bridge JA; Brent DA
    JAMA; 2004 Dec; 292(21):2578; author reply 2578-9. PubMed ID: 15572710
    [No Abstract]   [Full Text] [Related]  

  • 16. Adolescents with depression.
    Carroll BJ
    JAMA; 2004 Dec; 292(21):2578; author reply 2578-9. PubMed ID: 15572711
    [No Abstract]   [Full Text] [Related]  

  • 17. Depression in children and adolescents.
    Hazell P
    Clin Evid; 2006 Jun; (15):398-414. PubMed ID: 16973015
    [No Abstract]   [Full Text] [Related]  

  • 18. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.
    March J; Silva S; Petrycki S; Curry J; Wells K; Fairbank J; Burns B; Domino M; McNulty S; Vitiello B; Severe J;
    JAMA; 2004 Aug; 292(7):807-20. PubMed ID: 15315995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological management of treatment-resistant pediatric depression.
    Kratochvil CJ; Wagner KD; Emslie G; March J
    J Am Acad Child Adolesc Psychiatry; 2005 Feb; 44(2):198-200. PubMed ID: 15689734
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of adolescents with major depression: contributions of a major trial.
    Glass RM
    JAMA; 2004 Aug; 292(7):861-3. PubMed ID: 15316001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.